CD276 and breast cancer: The frequency of B7-H3-positive circulating epithelial tumor cells (CETCs) is significantly higher in breast cancer patients who receive radiotherapy than in patients who do not receive irradiation, suggesting that the upregulation of B7-H3 expression on CETCs could be a possible mechanism of acquired radioresistance in breast cancer patients14.